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Background: Angiogenesis is felt to be a factor in the
establishment and progression of cancer and cancer
metastasis. Vascular endothelial growth factor (VEGF) is
one of the most powerful stimulants of tumor angiogen-
esis identified. VEGF levels can be affected by physio-
logic stimuli and measured systemically.
Methods: Circulating VEGF levels were measured imme-
diately before and after laparoscopic colon surgery in 10
unselected sequential patients with a diagnosis requiring
surgical intervention for colon pathology.
Results: Preoperative VEGF ranged from 31.3 pcg/cc to
187 pcg/cc. Postoperative VEGF ranged from 45 pcg/cc
to 2228 pcg/cc. Factors of age, weight, diagnosis, length
of cumulative skin incisions, and the receipt of preoper-
ative blood products were considered. Data were com-
pared by t test and regression analysis. Although several
patients showed variability, some pronounced, in their
pre- and postoperative levels, no 1 factor reached statis-
tical significance as the cause of this variability. Utilizing
regression analysis, however, considering only those
patients in whom a diagnosis of cancer existed and who
received blood products, the length of the incision alone
accounted for an R2 change of 0.471. That is, in this sub-
set of patients, incision size alone accounted for almost
half of the variability in VEGF.
Conclusion: The data suggest a possible link between
incision size in colon surgery and levels of VEGF. The
sample size was insufficient for statistical significance.
The study also does not answer whether a systemic
release of VEGF at the time of surgery adversely affects
the clinical outcome in cases of colon cancer. The data
do warrant further investigation with a larger sample size
and clinical follow-up.
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INTRODUCTION
Recent work in cancer biology has focused on angio-
genesis.1 Although micrometastasis may remain viable in
a dormant state for some time, ingrowth of a blood sup-
ply may be necessary for a focus of cells to become a
growing, detectable, clinically evident metastasis.
Vascular endothelial growth factor (VEGF) is, in vitro, an
extraordinarily potent stimulator of tumor angiogenesis.
It may represent one of the significant factors responsi-
ble for the progression of disseminated micrometastasis
into stage 4 cancers.
Levels of VEGF have been shown to be elevated after
open colon surgery.2,3 We compare the levels of VEGF of
an unselected group of patients in whom laparoscopic
colorectal surgery was performed with those published
for a group of patients who had open colon surgery2 and
consider the therapeutic implications.2,3
METHODS 
Over a 2-month period, all patients (N=10) who were to
undergo colon surgery had peripheral blood drawn with-
in 1 hour prior to surgery and 1 postoperatively.
Specimens were submitted to an off-site laboratory
(Quest Diagnostics, Nichol’s Institute, San Juan
Capistrano, California) for analysis of levels of vascular
endothelial growth factor (VEGF) determined by using
the ELISA kit (Quantikine, R&D Systems, Minneapolis,
Minnesota). All patients were considered for and started
with a laparoscopic or laparoscopically assisted
approach. Patient data that were considered included:
age, weight, diagnosis (including cancer stage, where
applicable), the combined size of all the cutaneous inci-
sions (including trocar sites), and whether perioperative
transfusions were received.
RESULTS
Pre-operative VEGF ranged from 31.3 pcg/cc to 187
pcg/cc (Table 1). Postoperative VEGF ranged from 45
pcg/cc to 2228 pcg/cc. The pre- and postoperative dif-
ference ranged from –6 pcg/cc to 2197 pcg/cc (mean
241, median 24.5). Factors of age, weight, diagnosis,
cumulative length of skin incisions, and the receipt of
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preoperative blood products were considered. Data were
compared by t test and regression analysis.
Although several patients showed variability, some pro-
nounced, in their pre- and postoperative levels, no 1 fac-
tor reached statistical significance as the cause of this
variability. Utilizing regression analysis to compare the
Table 2.
Data From Rocca2 et al
Patients Platelets (pg/106) Duke’s Stage
Male: 22 Preoperative: 1.32 A: 1
Female: 8 Postoperative day 2: 1.61 B: 12
Median age: 62 Postoperative day 3: 2.43 C: 11
D: 6
Table 1.
Vascular Endothelial Growth Factor (VEGF) Data*
Patient Age Procedure Incision Size (cm) Diagnosis VEGF (pg/mL )†
Pre/Post
193 76 LARR 14+Trocars (2.7) CA B1 <31.3/2228
Status post 6 U FFP
136 77 RC 5+Trocars (2.7) VA 34/76 
140 77 LARR 14+Trocars  (2.7) CA+Obstruction <313/55
100 85 LARR 8.5 PR ?/148
165 72 HP + midline incision 20 including stoma Stricture/Obstruction <31.3/47
236 62 RSF 11 CA B2 31.3/56
174 49 Colotomy 11 FB of rectum 86/121
153‡ 72 RVC 8 Status post obstruction <31/104
145 72 Sigmoid Resection 7.5 PD w/abscess 49/53
193 58 RC 18 CA stage IV 187/173
Status post 4 U PRBC
Walled-off perforated cecum
149 77 RC 12 CA stage C 45/45
Status post 2 U PRBC
*CA: Cancer; FB: Foreign body; FFP: Fresh frozen plasma; HP: Hartmann procedure; LARR: Low anterior resection of rectum; PD:
Perforated diverticulum; PR: Prolapsed rectum; PRBC: packed red blood cells; RC: Right colectomy; RSF: Resection of splenic flexure;
RVC: Reversal of colostomy; VA: Villous adenoma.
†VEGF preoperative range: 31-86 pg/mL.
‡Platelets preop: 318; platelets postop: 308.
effects of different variables, it was determined that those
patients in whom a diagnosis of cancer existed and who
received blood products, the length of the incision alone
accounted for an R2 change of 0.471. That is, in this sub-
set of patients, incision size alone accounted for almost
half of the variability in VEGF.
DISCUSSION
The data suggest a possible link between incision size in
colon surgery and levels of VEGF. Circulating levels of
VEGF have recently been shown to be increased in the
early postoperative period in patients undergoing colon
cancer surgery via the open technique4 (Table 2).
In our group of patients in whom laparoscopic surgery
was undertaken, the sample size was insufficient for sta-
tistical significance. The study also does not answer
whether a systemic release of VEGF at the time of sur-gery adversely affects the clinical outcome in cases of
colon cancer.
A link may exist between the degree of physiologic insult
and a short-lived trophic effect on occult micrometastasis
that could be reflected in the long-term clinical out-
come4,5 of Stage III patients primarily and that may have
implications in choosing between open vs. minimally
invasive surgery. The data do warrant further investiga-
tion with a larger sample size and clinical follow-up.
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